Literature DB >> 3722176

The glucose-phosphorylating capacity of liver as measured by three independent assays. Implications for the mechanism of hepatic glycogen synthesis.

M Kuwajima, C B Newgard, D W Foster, J D McGarry.   

Abstract

In the fasted to fed transition liver glycogen derives mainly from gluconeogenic precursors. Why glucose is not used efficiently as a direct precursor of glycogen has become a controversial issue, in part because of disagreement over the question of how well liver can phosphorylate glucose under conditions prevailing postprandially. To try to resolve the matter the relative merits of two recently described assays, one spectrophotometric (A), the other isotopic (B), for monitoring rates of glucose phosphorylation in the high speed supernatant fraction of liver have been rigorously evaluated. A third method, also isotopic (C), was developed for use with unfractionated as well as fractionated liver homogenates. Using fasted rats and mice from different nutritional backgrounds the glucose-phosphorylating capacity of liver extracts was measured and compared with rates of hepatic glycogen synthesis observed during refeeding. Two of the assays (A and C) provided reliable data at all concentrations of glucose tested (5-100 mM), while method B exhibited shortcomings at lower substrate concentrations. The results clearly establish that in both rats and mice the ability of the liver to phosphorylate glucose at physiological concentrations is sufficient to support only 25-30% of postprandial glycogen synthesis. A limited capacity for glucose phosphorylation probably accounts for the fact that two-thirds of glycogen synthesized with refeeding after a fast is formed by the indirect (gluconeogenic) pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722176

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Fuel selection and carbon flux during the starved-to-fed transition.

Authors:  M C Sugden; M J Holness; T N Palmer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Role of the rat liver in the disposal of a glucose gavage.

Authors:  J Casado; J A Fernández-López; M J Argilés; M Alemany
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

3.  Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells.

Authors:  S D Hughes; J H Johnson; C Quaade; C B Newgard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

4.  Effects of nutritional status and acute variation in substrate supply on cardiac and skeletal-muscle fructose 2,6-bisphosphate concentrations.

Authors:  T J French; M J Holness; P A MacLennan; M C Sugden
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  Role of the direct and indirect pathways for glycogen synthesis in rat liver in the postprandial state.

Authors:  M T Huang; R L Veech
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats.

Authors:  S Halimi; F Assimacopoulos-Jeannet; J Terrettaz; B Jeanrenaud
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

7.  Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase.

Authors:  R R Gomis; J C Ferrer; J J Guinovart
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

8.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  Enhancement of glycogen concentrations in primary cultures of rat hepatocytes exposed to glucose and fructose.

Authors:  M A Parniak; N Kalant
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

10.  HIV protease inhibitors acutely impair glucose-stimulated insulin release.

Authors:  Joseph C Koster; Maria S Remedi; Haijun Qiu; Colin G Nichols; Paul W Hruz
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.